Dear Amazing Advocates,
The American Kratom Association is holding an important Advocacy Update Webinar this Wednesday, August 5, at 8:00 PM ET, and we strongly encourage every advocate to join us.
๐จ There are several urgent developments that could affect the future of kratom, and it is critical that advocates understand what is happening and how we can respond together.
During the webinar, the AKA team will provide updates on:
๐บ๐ธ Federal scheduling-related issues and the latest actions affecting natural kratom, 7-OH, and chemically manipulated products.
Understandably there is a lot of apprehension about what will actually happen and how to best protect natural kratom, so join us to discuss.
๐ The developing situation in North Dakota
๐๏ธ Important state and local legislative and regulatory actions
๐ The September anniversary event, including opportunities for advocates, veterans, and law enforcement supporters to participate
Your involvement matters. The time you spend contacting lawmakers, sharing your story, attending hearings, and supporting the AKA helps protect responsible kratom consumers across the country.
We appreciate you making time to join us Wednesday night.
๐ Register for the webinar:
https://t.co/xm4nFaxPEy
Thank you for your time, your advocacy, and everything you continue to do to protect kratom consumer freedom. We know these ongoing battles require a great deal from our advocates, and we are deeply grateful for your continued help.
Together, we can protect responsible access to natural kratom.
๐ WEBINAR TONIGHT โ Wednesday at 8:00 PM ET
A quick reminder: August Advocacy Update Webinar is TONIGHT, Wednesday, August 5, at 8:00 PM ET.
๐ REGISTER HERE:
https://t.co/xm4nFaxPEy
Federal DEA Scheduling action is top of mind so join to get the latest.
Other Key Items:
๐จ The developing situation in North Dakota
๐บ๏ธ Important state and local legislative and regulatory actions
๐บ๐ธ The September anniversary event, including opportunities for advocates, veterans, and law enforcement supporters to participate
Federal Register document 2026-13581 sets out the Drug Enforcement Administration's intent to temporarily schedule Mitragynine Pseudoindoxyl (MP), MGM-15, and MGM-16.